SEC Form 4 · accession 0001127602-17-009208
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 3:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2017 | S | 100 | $87.435 | D | 391,753 | D | |
| Common Stock | Feb 28, 2017 | S | 500 | $87.44 | D | 391,253 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.45 | D | 391,153 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.48 | D | 390,953 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.49 | D | 390,653 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.50 | D | 390,453 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.51 | D | 390,253 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.53 | D | 389,953 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.55 | D | 389,853 | D | |
| Common Stock | Feb 28, 2017 | S | 302 | $87.56 | D | 389,551 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.59 | D | 389,351 | D | |
| Common Stock | Feb 28, 2017 | S | 90 | $87.605 | D | 389,261 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.615 | D | 389,161 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.63 | D | 388,961 | D | |
| Common Stock | Feb 28, 2017 | S | 10 | $87.67 | D | 388,951 | D | |
| Common Stock | Feb 28, 2017 | S | 140 | $87.675 | D | 388,811 | D | |
| Common Stock | Feb 28, 2017 | S | 80 | $87.69 | D | 388,731 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.695 | D | 388,531 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.70 | D | 388,231 | D | |
| Common Stock | Feb 28, 2017 | S | 516 | $87.71 | D | 387,715 | D | |
| Common Stock | Feb 28, 2017 | S | 43 | $87.75 | D | 387,672 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.77 | D | 387,472 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $87.79 | D | 387,272 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.80 | D | 387,172 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $87.81 | D | 387,072 | D | |
| Common Stock | Feb 28, 2017 | S | 300 | $87.82 | D | 386,772 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.